in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

Size: px
Start display at page:

Download "in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D."

Transcription

1 Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative and postoperative characteristics of a group of 16 patients who died unexpectedly and a control group of 52 late survivors with aortic protheses are reviewed. There were no preoperative differences between the groups for duration of congestive heart failure, electrocardiographic findings, cardiothoracic ratio, or hemodynamic findings. However, on the standard electrocardiogram postoperatively, there were more ventricular arrhythmias in the patients who died suddenly (7 of 16 or 44%) compared with the survivors (5 of 49 or 10%) (p < 0.05). There were more patients with congestive failure in the study group (10 of 16 or 62%) compared with the controls (4 of 52 or 8%) (p < 0.05). Patients exhibiting these findings are at risk of sudden death. Arrhythmia monitoring prior to discharge may also be helpful in selecting patients for antiarrhythmia treatment. One of the important unresolved problems following aortic valve replacement is late sudden death. Its incidence in reported series ranges between 7 and 38% [l-31. The present investigation was undertaken to determine whether there are any preoperative or postoperative findings that can be used to predict which patients are predisposed to sudden death following aortic valve replacement. Material and Methods The study population for sudden death was composed of patients who underwent Starr- Edwards aortic valve replacement at the Uni- From the Department of Internal Medicine, Division of Cardiology, Department of Thoracic Surgery, and Department of Biostatistics, University of Michigan Medical Center, Ann Arbor, MI. Accepted for publication Feb 22, Address reprint requests to Dr. Santinga, Department of Internal Medicine, Division of Cardiology, University of Michigan Medical Center, 1405 E Ann St, Ann Arbor, MI versity of Michigan Medical Center from 1967 to Patients with associated cardiac defects or clinically significant disease of other cardiac valves were excluded as were patients who died of cerebral embolism or hemorrhage. Unexpected death was defined as a nonhospitalized patient who had an acute event with loss of consciousness and was either dead or in ventricular fibrillation on arrival at a medical facility. Sixteen patients, 3 women and 13 men, fulfilled these criteria. They ranged from 27 to 67 years old (mean age, 52 years). A group of 52 patients who were long-term survivors of isolated Starr-Edwards aortic replacement served as the control group. There were 13 female and 39 male patients ranging from 17 to 74 years old (mean age, 52 years). They had been operated on during the same period as the study group, and all had the Starr-Edwards 1260 aortic prosthesis. These patients had survived at least 2 years and had a mean follow-up of forty-six months. Preoperatively, the types of valve lesion in the 16 patients who died suddenly were as follows: aortic stenosis, 6 patients (38%); mixed lesions, 3 patients (19%); and aortic insufficiency, 7 patients (44%). Of 48 survivors, 21 (44%) had aortic stenosis; 12 (25%) had mixed lesions; and 15 (31 YO) had aortic insufficiency. In addition, 4 patients had replacement of a defective prosthetic valve. The preoperative New York Heart Association (NYHA) Functional Classification for the two groups was as follows: Class I, none in the study group and 2 (4%) in the control group; Class 11, 8 (50%) in the study group and 27 (52%) in the control group; Class 111, 7 (44%) in the study group and 22 (42%) in the controls; and Class IV, 1(6%) in the study group and 1 (2%) in the controls. The preoperative electrocardiograms were reviewed for ventricular arrhythmias, left ventricular hypertrophy, and conduction abnormalities (Table). There were no differences by John T. Santinga

2 250 The Annals of Thoracic Surgery Vol 29 No 3 March 1980 between the two groups in the preoperative tracings. Ventricular arrhythmias were recorded when there were three or more premature ventricular beats on the mounted 12-lead electrocardiogram taken with a single-channel machine. The tracings averaged from 15 to 25 complexes. Left ventricular hypertrophy was read when the voltage exceeded the normals given in the Minnesota code [41. Conduction abnormalities were read when the QRS interval exceeded the normals in this code and were classed as complete right and left bundle-branch block. Infarction was also read when the Q wave exceeded the criteria given in the Minnesota code. The mean duration of congestive heart failure prior to operation was 1.9 years for the study group and 3 years for the control group. The cardiothoracic ratio was taken from a preoperative posteroanterior chest roentgenogram. For 13 patients in the study group for whom roentgenograms were available, the preoperative cardiothoracic ratio was 0.58; it was 0.56 for the 37 patients in the control group for whom roentgenograms were available. Preoperative cardiac catheterization was carried out in all patients. Hemodynamic data for the study and control groups were available for some patients in each group. Average left ventricular end-diastolic pressure was 22 mm Hg for 13 patients in the sudden death group and 24 mm Hg for 49 of the survivors. Average pulmonary artery systolic pressure was 48 mm Hg for 12 patients in the sudden death group and 41 mm Hg for 45 survivors. The aortic gradient was 68 mm Hg for 10 patients in the study group and 75 mm Hg for 36 patients in the control group. The left ventricular ejection fraction was calculated from the right anterior oblique view using standard angiography of the left ventricle. Average left ventricular ejection fraction was 61% for 10 patients in the study group and 63% for 40 of the survivors. The coronary arteriograms were graded by the scoring system of Friesinger and co-workers [5]: no disease = 0; < 50% = 1; 50-90% = 2; multiple 50-90% = 3; 90-99% = 4; and total occlusion = 5. The individual scores for the left anterior descending, lateral circumflex, and right coronary arteries were added together to give the total score. Seven patients in the study group had normal coronary arteriography, with all the scores in the range of 0 to 3. Twentyeight patients in the control group had normal coronary arteriograms; 1 had a score of 2 to 5 and 1, a score of greater than 6. A uniform perfusion technique was used throughout with a bubble oxygenator at a flow rate of 2.5 liters per minute per square meter of body surface. In 75% of the patients, coronary perfusion at a temperature of 28 C was employed during aortic valve replacement. An attempt was made to maintain the heart in normal sinus rhythm during the time of aortic cross-clamping. In 25% of the patients, hypothemic ischemic arrest (28 C) was employed. Results Several methods of myocardial protection were used. For 6 patients in the study group, mean coronary perfusion time with the heart beating was 84 minutes (range, 60 to 120 minutes). For 22 patients in the control group, it was 86 minutes (range, 52 to 136 minutes). Mean coronary perfusion time with the heart in ventricular fibrillation was 77 minutes (range, 60 to 113 minutes) for 6 patients in the study group; for 18 patients in the control group, it was 85 minutes (range, 53 to 132 minutes). The time of hypothermic arrest averaged 57 minutes (range, 47 to 67 minutes) for 4 patients in the study group; it was 61 minutes (range, 51 to 87 minutes) for 13 patients in the control group. There were no significant differences between the two groups regarding the method of myocardial preservation or duration of cross-clamping. Postoperatively, NYHA Functional Classification was as follows: Class I, 3 patients (19'/0) in the study group and 34 (65%) in the control group; Class 11, 9 (56%) in the study group and 18 (35%) in the control group; Class 111, 4 (25%) in the study group. There were no patients in Class IV. Fewer patients in the sudden death group were in Class I compared with the control group (p < 0.05). The frequency and severity of postoperative congestive failure for both groups also show a significant increase in congestive failure in the

3 251 Santinga et al: Late Sudden Death after AVR Electrocardiographic Findings in the Sudden Death Patients (Group A) Compared with a Control Group of Survivors (Group B)a Finding LVH Conduction defect Pacing Infarction Ventricular arrhythmias Preoperative Percentages Postoperative Percentages Group A Group B (N = 16) (N = 49) Group A Group B "In parentheses are the numbers.of patients with the electrocardiographic abnormality. < 0.05 by the chi-square method. LVH = left ventricular hypertrophy. sudden death group compared with the control group (p < 0.05). Of the 16 patients in the study group, 5 (31%) had severe congestive failure; 5 (31%) had moderate failure; and 6 (38%) had no congestive failure. Of the 52 survivors, only 2 (4%) had severe congestive failure; only 2 (4%) had moderate failure; and 48 (92%) had no failure. Onset of congestive failure occurred within 2 years of operation in 8 of the 10 patients in the study group. Digitalis and diuretics were used by 11 of the 16 patients in the study group and 20 of the 52 patients in the control group. The cardiothoracic ratio for the postoperative period remained at 0.58 for the group experiencing sudden death and decreased in the survivors to The interval from operation to death for the survivors is as follows: 6 patients died within the first year; 6 patients in the second year; and 1 patient each year for the third, fourth, fifth, and tenth years. The postoperative electrocardiographic findings for the two groups are listed in the Table. The most striking finding is the significantly higher incidence of ventricular arrhythmias in the sudden death group in comparison to the survivors, 44% and 10940, respectively (p < 0.05). Comment As a result of improvements in intraoperative and postoperative management, aortic valve replacement can now be accomplished with an operative risk of 5% or less. Long-term survival following aortic valve replacement is influenced by the severity of the preexisting heart disease, intraoperative injury to the myocardium, and prosthetic-valve related complications [6, 71. The cardiac causes of death include congestive heart failure and myocardial infarction. Some are sudden and unexplained. The exact incidence of sudden unexplained deaths is difficult to determine since sudden deaths are usually classified with the myocardial causes of late deaths in most reported series. Isom and colleagues 181 in 1977 reported that of 47 late deaths from myocardial factors, 14 were sudden and unexplained (30% incidence). The results of the present study demonstrate that none of the preoperative indices could predict which patients would die suddenly following aortic valve replacement. There was no statistically significant difference between the long-term survivors and those who died suddenly with respect to Functional Class, type of valve lesion, cardiothoracic ratio, duration of congestive heart failure, incidence of ventricular arrhythmias, and electrocardiographic findings of myocardial infarction, intraventricular conduction abnormalities, left ventricular hypertrophy, left ventricular end-diastolic pressure, or left ventricular ejection fraction. However, patients who died suddenly did exhibit postoperative characteristics that were different from those of long-term survivors. In those patients who died suddenly, there was an increased postoperative incidence of congestive heart failure and a greater frequency of ven-

4 252 The Annals of Thoracic Surgery Vol 29 No 3 March 1980 tricular arrhythmias. The postoperative cardiothoracic ratios in the study group did not decrease following operation while those in the survivors did (p < 0.05). The increased frequency of postoperative congestive heart failure in the group dying suddenly cannot be explained on the basis of a greater impairment of function preoperatively since the preoperative duration of congestive heart failure, cardiothoracic ratio, left ventricular end-diastolic pressure, and ejection fraction were similar in the two groups of patients. Eleven of the 16 patients with sudden death were on a regimen of digitalis and diuretics. Therefore digitalis toxicity is a possibility. However, 20 of the longterm survivors also were on a regimen of these medications. This reduces the likelihood that digitalis toxicity is a major cause of sudden death. That the major cause of death following aortic valve replacement in our institution and in other reported series is myocardial failure and that most deaths in this and other series occur within 2 to 3 years of operation suggest that the most probable cause of death is operative injury, since in our patients the preexisting myocardial function was the same for both groups. Subendocardial necrosis is the most common cause of death following technically successful cardiac operations [ The hearts of as many as 90% of the patients who died after openheart operation have left ventricular subendocardial necrosis. It can occur without anatomical obstruction of the coronary arteries and is thought to be caused by a discrepancy between subendocardial oxygen supply and demand during the operative period. In our patients who died late, infarctions, if present, were likely subendocardial in nature; only 1 of the 16 patients had electrocardiographic evidence of a transmural infarction. We would agree with Isom and co-workers [7, 81 that these deaths result from operative infarction, which increases the propensity for sudden fatal arrhythmias. This has been shown for coronary disease but is less well recognized for valvular disease The increase in ventricular arrhythmias postoperatively in the study group would be in agreement with this mechanism. Operative injury would also ac- count for the related high incidence of recurrent congestive heart failure in those patients who died suddenly. Of interest is the observation that sudden death occurred irrespective of the method of myocardial preservation in our series. It occurred in patients in whom aortic valve replacement was carried out utilizing coronary perfusion while keeping the empty heart beating throughout the period of aortic cross-clamping. This would suggest that an optimum method of preserving the hypertrophied myocardium of patients with aortic disease has not as yet been perfected. The results of this study suggest that left ventricular dysfunction, probably resulting from intraoperative injury, is a major causative factor in those patients who die suddenly and unexpectedly following aortic valve replacement. Those at risk to die suddenly are patients in whom congestive heart failure and ventricular ectopy occur following aortic valve replacement. In addition, the cardiothoracic ratio on chest roentgenogram in these patients fails to decrease in size. Patients with this clinical profile should be carefully evaluated using periodic Holter monitoring and, if complex ventricular arrhythmias are detected, the use of antiarrhythmic drugs should be considered. Future endeavors to prevent this cataclysmic complication should center around improved methods of myocardial preservation during operation. References Barnhorst DA, Oxman HA, Connolly DC, et al: Long-term followup of isolated replacement of the aortic or mitral valve with Starr-Edwards prosthesis. Am J Cardiol35:228, 1975 Braun LO, Kincaid OW, McGoon DC: Prognosis of aortic valve replacement in relation to the preoperative heart size. J Thorac Cardiovasc Surg 65:381, 1973 Buckberg GD, Towers 8, Paglia DE, et al: Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 64:669, 1972 DeBoer A, Midell AI: Isolated aortic valve replacement: analysis of factors influencing survival after replacement with the Starr-Edwards prosthesis. Ann Thorac Surg 17:360, 1974 Friesinger GC, Page EE, Ross RS: Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 83:78, 1970 Hodam R, Starr A, Raible D, et al: Totally cloth-

5 253 Santinga et al: Late Sudden Death after AVR covered prosthesis: a review of two years clinical experience. Circulation 41,42:Suppl 2:II-33, Isom 0, Dembrow JM, Glassman E, et al: Factors influencing long-term survival after isolated aortic valve replacement. Circulation 49,5O:Suppl 2:II-154, Isom 0, Spencer F, Glassman E, et al: Longterm results in 1,375 patients undergoing valve replacements with the Starr-Edwards clothcovered steel ball prosthesis. Ann Surg 186:310, Najafi H, Henson D, Dye WS, et al: Left ven- tricular hemorrhagic necrosis. Ann Thorac Surg 7:550, Rose GA, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Organization, 1968, p Taber RE, Morales AR, Fine G: Myocardial necrosis and the postoperative low-cardiac-output syndrome. Ann Thorac Surg 4:12, Weaver WD, Lorch GS, Alvarez HA, et al: Angiographic findings and prognostic indicators in patients resuscitated from sudden cardiac death. Circulation 54395, 1976 Notice from the American Board of Thoracic Surgery The American Board of Thoracic Surgery now requires that candidates pass both the written and oral portions of the certifying examination. In 1980 and thereafter, a written examination will be given prior to the oral examination. It will be necessary to pass the written examination before the oral examination can be taken. The closing date for registration for 1981 is August 1,1980. The exact times and places of these examinations will be announced later. A candidate applying for admission to the 1981 certifying examination must fulfill all the requirements for the Board in force at the time the application is received. Please address all communications to the American Board of Thoracic Surgery, E Seven Mile Road, Detroit, MI

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

Open-Heart Surgery in Patients More than 65 Years Old

Open-Heart Surgery in Patients More than 65 Years Old Open-Heart Surgery in Patients More than 65 Years Old Donald A. Barnhorst, M.D., Emilio R. Giuliani, M.D., James R. Pluth, M.D., Gordon K. Danielson, M.D., Robert B. Wallace, M.D., and Dwight C. McGoon,

More information

Coronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates

Coronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates Coronary arteriography in complicated acute myocardial ; clinical and angiographic correlates Luis M. de la Fuente, M.D. Buenos Aires, Argentina From January 1979 to June 30, 1979, we performed coronary

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis CASE REPORTS Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis Martin J. Nathan, M.D., Roman W. DeSanctis, M.D., Mortimer J. Buckley, M.D., Charles A. Sanders, M.D., and W. Gerald Austen,

More information

Coronary Atherosclerosis in Valvular Heart Disease

Coronary Atherosclerosis in Valvular Heart Disease Coronary Atherosclerosis in Valvular Heart Disease Jerome Lacy, M.D., Robert Goodin, M.D., Daniel McMartin, M.D., Ronald Masden, M.D., and Nancy Flowers, M.D. ABSTRACT To evaluate the usefulness of routine

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

Table 1. Postoperative Ventricular Arrhythmias

Table 1. Postoperative Ventricular Arrhythmias Unanticipated Postoperative Ventricular Tachyarrhythmias Irving L. Kron, M.D., John P. DiMarco, M.D., Ph.D., P. Kent Harman, M.D., Ivan K. Crosby, M.D., Robert M. Mentzer, Jr., M.D., Stanton P. lan, M.D.,

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**

More information

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis W. C. Alford, Jr., M.D., I. J. Shaker, M.D., C. S. Thomas, Jr., M.D., W. S. Stoney, M.D., G. R. Burrus, M.D., and H. L. Page,

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia Disorder of the Breast Approach to the Patient with Chest Pain Anthony J. Minisi, MD Department of Internal Medicine, Division of Cardiology Virginia Commonwealth University School of Medicine William

More information

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of

More information

Evaluation of pacing for heart block

Evaluation of pacing for heart block British Heart Journal, I97I, 33, 120-I24. Evaluation of pacing for heart block in myocardial infarction C. C. Watson and M. J. Goldberg From Leicester Regional Cardiothoracic Unit, Groby Road Hospital,

More information

Demonstration of Uneven. the infusion on myocardial temperature was insufficient

Demonstration of Uneven. the infusion on myocardial temperature was insufficient Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

Coronary arteriographic study of mild angina

Coronary arteriographic study of mild angina British HeartJournal, I975, 37, 752-756. Coronary arteriographic study of mild angina W. Walsh, A. F. Rickards, R. Balcon From the National Heart Chest Hospitals, London Chest Hospital, London The results

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Introduction. Study Design. Background. Operative Procedure-I

Introduction. Study Design. Background. Operative Procedure-I Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt Ann Thorac Surg 2009;87:178 86 86 Addressor: R1 胡祐寧 2009/3/4 AM7:30 SICU 討論室 Introduction Hypoplastic

More information

Reversal of Advanced Left Ventricular Dysfunction Following Aortic Valve Replacement for Aortic Stenosis

Reversal of Advanced Left Ventricular Dysfunction Following Aortic Valve Replacement for Aortic Stenosis Reversal of Advanced Left Ventricular Dysfunction Following Aortic Valve Replacement for Aortic Stenosis Robert P. Croke, M.D., Roque Pifarre, M.D., Henry Sullivan, M.D., Rolf Gunnar, M.D., and Henry Loeb,

More information

MYOCARDIALINFARCTION. By: Kendra Fischer

MYOCARDIALINFARCTION. By: Kendra Fischer MYOCARDIALINFARCTION By: Kendra Fischer Outline Definition Epidemiology Clinical Aspects Treatment Effects of Exercise Exercise Testing Exercise Rx Summary and Conclusions References Break it down MYOCARDIAL

More information

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery Aortic stenosis (AS) is characterized as a high-risk index for cardiac complications during non-cardiac surgery. A critical analysis of old

More information

complicating myocardial infarction

complicating myocardial infarction British Heart Journal, I970, 32, 21. Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction G. Terry,1 C. W. Vellani, M. R. Higgins, and A. Doig From the

More information

Appendix D Output Code and Interpretation of Analysis

Appendix D Output Code and Interpretation of Analysis Appendix D Output Code and Interpretation of Analysis 8 Arrhythmia Code No. Description 8002 Marked rhythm irregularity 8110 Sinus rhythm 8102 Sinus arrhythmia 8108 Marked sinus arrhythmia 8120 Sinus tachycardia

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

Pulmonary Valve Replacement

Pulmonary Valve Replacement Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

HEART CONDITIONS IN SPORT

HEART CONDITIONS IN SPORT HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One

More information

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,

More information

Cardiovascular System Notes: Heart Disease & Disorders

Cardiovascular System Notes: Heart Disease & Disorders Cardiovascular System Notes: Heart Disease & Disorders Interesting Heart Facts The Electrocardiograph (ECG) was invented in 1902 by Willem Einthoven Dutch Physiologist. This test is still used to evaluate

More information

EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION

EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION James R. Stewart,* John K. Gibson,? and Benedict R. Lucchesi t Departments of Internal Medicine *

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery*

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery* Clin. Cardiol. 7, 179-183 (1984) @ Clinical Cardiology Publishing Co., Inc. Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous

More information

CONGENITAL AORTIC STENOSIS PRODUCED BY A UNICOMMISSURAL VALVE

CONGENITAL AORTIC STENOSIS PRODUCED BY A UNICOMMISSURAL VALVE Brit. Heart J., 1965, 27, 505. CONGENITAL AORTIC STENOSIS PRODUCED BY A UNICOMMISSURAL VALVE WILLIAM C. BY ROBERTS AND ANDREW G. MORROW From the Clinic of Surgery, National Heart Institute, National Institutes

More information

Case Report Preoperative Assessment of Anomalous Right Coronary Artery Arising from the Main Pulmonary Artery

Case Report Preoperative Assessment of Anomalous Right Coronary Artery Arising from the Main Pulmonary Artery Case Reports in Medicine Volume 2011, Article ID 642126, 4 pages doi:10.1155/2011/642126 Case Report Preoperative Assessment of Anomalous Right Coronary Artery Arising from the Main Pulmonary Artery Marshall

More information

4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.

4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium. Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

December 2018 Tracings

December 2018 Tracings Tracings Tracing 1 Tracing 4 Tracing 1 Answer Tracing 4 Answer Tracing 2 Tracing 5 Tracing 2 Answer Tracing 5 Answer Tracing 3 Tracing 6 Tracing 3 Answer Tracing 6 Answer Questions? Contact Dr. Nelson

More information

DIAGNOSTIC CRITERIA OF AMI/ACS

DIAGNOSTIC CRITERIA OF AMI/ACS DIAGNOSTIC CRITERIA OF AMI/ACS Diagnostic criteria are used to validate clinical diagnoses. Those used in epidemiological studies are here below reported. 1. MONICA - Monitoring trends and determinants

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

THE ELECTROCARDIOGRAM IN ENDOMYOCARDIAL FIBROSIS

THE ELECTROCARDIOGRAM IN ENDOMYOCARDIAL FIBROSIS BY From the Department of Medicine, Makerere College, and Mulago Hospital, Kampala, Uganda Received May 11, 1959 Endomyocardial fibrosis is an important cause of heart failure in this part of Africa. The

More information

Results of Reoperation

Results of Reoperation Results of Reoperation for Recurrent Angina Pectoris William I. Norwood, M.D., Lawrence H. Cohn, M.D., and John J. Collins, Jr., M.D. ABSTRACT Although a coronary bypass operation improves the quality

More information

ATRIAL SEPTAL DEFECTS

ATRIAL SEPTAL DEFECTS ORIGINAL STUDY Long-term follow-up of children after repair of atrial septal defects JAMES MANDELIK, MD; DOUGLAS S. MOODIE, MD; RICHARD STERBA, MD; DANIEL MURPHY, MD; ELIOT ROSENKRANZ, MD; SHARON MEDENDORP,

More information

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger

More information

12 Lead ECG Interpretation

12 Lead ECG Interpretation 12 Lead ECG Interpretation Julie Zimmerman, MSN, RN, CNS, CCRN Significant increase in mortality for every 15 minutes of delay! N Engl J Med 2007;357:1631-1638 Who should get a 12-lead ECG? Also include

More information

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD The Electrocardiogram part II Dr. Adelina Vlad, MD PhD Basic Interpretation of the ECG 1) Evaluate calibration 2) Calculate rate 3) Determine rhythm 4) Determine QRS axis 5) Measure intervals 6) Analyze

More information

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Title: Automatic External Defibrillators Division: Medical Management Department: Utilization Management

Title: Automatic External Defibrillators Division: Medical Management Department: Utilization Management Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,

More information

Cardiology/Cardiothoracic

Cardiology/Cardiothoracic Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00

More information

Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy

Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy Case Reports Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy Kazufumi TSUCHIHASHI, M.D., Akihito TSUCHIDA, M.D., Nobuichi HIKITA, M.D., Shuji YONEKURA, M.D.,

More information

CME Article Brugada pattern masking anterior myocardial infarction

CME Article Brugada pattern masking anterior myocardial infarction Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Electrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates

Electrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates Electrocardiograms Electrical System Overview James Lamberg 2/ 74 Action Potentials 12-Lead Positioning 3/ 74 4/ 74 Values To Memorize Inherent Rates SA: 60 to 100 AV: 40 to 60 Ventricles: 20 to 40 Normal

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology Aortic Stenosis: UPDATE 2010 Anjan Sinha, MD Krannert Institute of Cardiology None Disclosures 67-Year-Old Male Dyspnea and angina Class III heart failure No PND or orthopnea 3/6 late peak SEM Diminished

More information

Myocardial Infarction

Myocardial Infarction Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the

More information

HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE

HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE Lusyun Kumar Yadav * and Jin li Jun Department of Cardiology,

More information

Extreme pulmonary hypertension caused by mitral valve disease

Extreme pulmonary hypertension caused by mitral valve disease British Heart Journal, I975, 37, 74-78. Extreme pulmonary hypertension caused by mitral valve disease Natural history and results of surgery C. Ward and B. W. Hancock From the Cardio-Thoracic Unit, Northern

More information

Ventricular Fibrillation durinp: Cardiopulmonary B ass: Lo&Term Effects on Myocardial Morp yfl ology and Function

Ventricular Fibrillation durinp: Cardiopulmonary B ass: Lo&Term Effects on Myocardial Morp yfl ology and Function Ventricular Fibrillation durinp: Cardiopulmonary B ass: Lo&Term Effects on Myocardial Morp yfl ology and Function Wolfgang Schraut, M.D., John J. Lamberti, M.D., Ken Kampman, M.D., and Seymour Glagov,

More information

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)

More information

Case 1. Case 2. Case 3

Case 1. Case 2. Case 3 Case 1 The correct answer is D. Occasionally, the Brugada syndrome can present similar morphologies to A and also change depending on the lead position but in the Brugada pattern the r is wider and ST

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

BUSINESS. Articles? Grades Midterm Review session

BUSINESS. Articles? Grades Midterm Review session BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization

More information

Ten-Year Follow-up in Aortic Valve Replacement Using the Bjork-Shiley Prosthesis

Ten-Year Follow-up in Aortic Valve Replacement Using the Bjork-Shiley Prosthesis Ten-Year Follow-up in Aortic Valve Replacement Using the Bjork-Shiley Prosthesis David Cheung, M.D., Robert J. Flemma, M.D., Donald C. Mullen, M.D., Denvard Lepley, Jr., M.D., Alfred J. Anderson, M.S.,

More information

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees

More information

MITRAL STENOSIS AND HYPERTENSION

MITRAL STENOSIS AND HYPERTENSION MITRAL STENOSIS AND HYPERTENSION IAN R. BY GRAY From University College Hospital Received April 15 1953 Hypertension is often found in cases of mitral stenosis but reports of the frequency of the association

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

ABNORMAL ORIGIN OF THE LEFT CIRCUMFLEX CORONARY ARTERY FROM THE RIGHT CORONARY ARTERY

ABNORMAL ORIGIN OF THE LEFT CIRCUMFLEX CORONARY ARTERY FROM THE RIGHT CORONARY ARTERY ABNORMAL ORIGIN OF THE LEFT CIRCUMFLEX CORONARY ARTERY FROM THE RIGHT CORONARY ARTERY Antonio Fuertes, M.D.,* Mario Trivellato, M.D.,** and Jeff Z. Brooker, M.D.*** INTRODUCTION Primary anomalies of the

More information

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?

More information

Lab 16. The Cardiovascular System Heart and Blood Vessels. Laboratory Objectives

Lab 16. The Cardiovascular System Heart and Blood Vessels. Laboratory Objectives Lab 16 The Cardiovascular System Heart and Blood Vessels Laboratory Objectives Describe the anatomical structures of the heart to include the pericardium, chambers, valves, and major vessels. Describe

More information

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man.

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man. HISTORY 45-year-old man. CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: His dyspnea began suddenly and has been associated with orthopnea, but no chest pain. For two months he has felt

More information

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O.

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O. CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O. INTRODUCTION Form of imprisonment in 1818 Edward Smith s observations TECHNIQUE Heart rate Blood pressure ECG parameters Physical appearance INDICATIONS

More information

Case Report Thirty Years Later: Evolution of Treatment for Acute Left Main Coronary Artery Occlusion

Case Report Thirty Years Later: Evolution of Treatment for Acute Left Main Coronary Artery Occlusion Case Reports in Cardiology Volume 2016, Article ID 7360682, 4 pages http://dx.doi.org/10.1155/2016/7360682 Case Report Thirty Years Later: Evolution of Treatment for Acute Left Main Coronary Artery Occlusion

More information

Systolic and Diastolic Function After Patch Reconstruction of Left Ventricular Aneurysms

Systolic and Diastolic Function After Patch Reconstruction of Left Ventricular Aneurysms Systolic and Diastolic Function After Patch Reconstruction of Left Ventricular Aneurysms Tetsuji Kawata, MD, Soichiro Kitamura, MD, Kanji Kawachi, MD, Ryuichi Morita, MD, Yoshitsugu Yoshida, MD, and Junichi

More information

Mitral valve replacement

Mitral valve replacement Mitral valve replacement Long-term results, with particular reference to changes in pulmonary vascular resistance Thorax (1968), 23, 1. J. HAMER, T. BOULTON, J. FLEMING, G. W. HAYWARD, I. M. HILL, I. MONRO,

More information

Disclosure. 3. ST depression indicative of ischemia is most commonly observed in leads: 1. V1-V2. 2. I and avl 3. V

Disclosure. 3. ST depression indicative of ischemia is most commonly observed in leads: 1. V1-V2. 2. I and avl 3. V Interpreting Stress Induced Ischemia by ECG, Bundle Branch Block & Arrhythmias Disclosure Gregory S Thomas MD, MPH Medical Director, MemorialCare Heart & Vascular Institute, Long Beach Memorial Astellas

More information

Recommended Evaluation Data Excerpt from NVIC 04-08

Recommended Evaluation Data Excerpt from NVIC 04-08 Recommended Evaluation Data Excerpt from NVIC 04-08 Purpose: This document is an excerpt from the Medical and Physical Evaluations Guidelines for Merchant Mariner Credentials, contained in enclosure 3

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Thank you for taking the time to review the draft Cardiovascular Diseases and Disorders chapter. Please provide

More information

Coenzyme Qlo: The Prophylactic Effect on Low Cardiac Output Following Cardiac Valve Replacement

Coenzyme Qlo: The Prophylactic Effect on Low Cardiac Output Following Cardiac Valve Replacement Coenzyme Qlo: The Prophylactic Effect on Low Cardiac Output Following Cardiac Valve Replacement Jiro Tanaka, M.D., Ryuji Tominaga, M.D., Mochikazu Yoshitoshi, M.D., Kanji Matsui, M.D., Masataka Komori,

More information

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager. All About STEMIs Presented By: Brittney Urvand, RN, BSN, CCCC Essentia Health Fargo Cardiovascular Program Manager Updated 10/2/2018 None Disclosures Objectives Identify signs and symptoms of a heart attack

More information